ISPN & CGFNS Psychopharmacology for Psychiatric Nurses 2

Question 1

Which medication is FDA-approved for the treatment of opioid use disorder by blocking opioid receptors?

Accepted Answer

Naltrexone (Vivitrol)

Answer

Naltrexone is an opioid antagonist FDA-approved for treating opioid use disorder and alcohol use disorder by blocking the euphoric effects of opioids.

Question 2

A patient on an SSRI develops agitation, hyperthermia, diaphoresis, and muscle rigidity. Which condition should the nurse suspect?

Accepted Answer

Serotonin syndrome

Answer

The combination of agitation, hyperthermia, diaphoresis, and rigidity is the classic triad of serotonin syndrome, a dangerous reaction to serotonergic drugs.

Question 3

Which mood stabilizer requires monitoring of serum levels and is associated with teratogenic risk including neural tube defects?

Accepted Answer

Valproate (Depakote)

Answer

Valproate is associated with neural tube defects and requires serum level monitoring; it is contraindicated in pregnancy due to high teratogenic risk.

Question 4

Which medication is used as a 'prn' (as-needed) oral intervention for acute agitation in psychiatric inpatient settings?

Accepted Answer

Lorazepam (Ativan)

Answer

Lorazepam, a benzodiazepine, is commonly administered on a PRN basis for acute agitation in inpatient psychiatric settings due to its rapid onset.

Question 5

A patient taking an atypical antipsychotic gains 15 pounds and develops hyperglycemia. These findings are characteristic of which side effect syndrome?

Accepted Answer

Metabolic syndrome

Answer

Atypical antipsychotics are associated with metabolic syndrome, which includes weight gain, hyperglycemia, dyslipidemia, and increased cardiovascular risk.

ISPN & CGFNS Practice Test

ISPN & CGFNS Practice Test

ISPN & CGFNS Psychopharmacology for Psychiatric Nurses 2